CSIMarket
 


Bio rad Laboratories Inc   (BIO)
Other Ticker:  
 

Bio Rad Laboratories Inc 's Total Debt to Equity

BIO's quarterly Total Debt to Equity and Total Debt, Equity growth


Despite a net increase in borrowings by 0.03%, Bio Rad Laboratories Inc managed to enhance Total Debt to Equity in the forth quarter 2023 to 0.14, falling below the company's typical Total Debt to Equity.

Within Laboratory Analytical Instruments industry Bio rad Laboratories Inc achieved the lowest Total Debt to Equity in the forth quarter 2023. While Total Debt to Equity total ranking has deteriorated compared to the third quarter 2023 from 71 to 115 .

Explain Debt to Equity Ratio?
What is the structure of BIO´s Total Debt?
How valuable is the BIO´s Equity?


BIO Total Debt to Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -9.09 % -0.44 % -5.33 % -4.12 % -29.65 %
Y / Y Total Debt Change 0.11 % 0.12 % 0.12 % 0.11 % 10789.58 %
Total Debt to Equity MRQ 0.14 0.14 0.14 0.12 0.12
BIO's Total Ranking # 115 # 71 # 288 # 321 # 123
Seq. Equity Change 3.86 % -0.36 % -13.49 % 1.54 % 13.74 %
Seq. Total Debt Change 0.03 % 0.03 % 0.03 % 0.03 % 0.04 %



Total Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 16
Overall Market # 115


Total Debt to Equity Statistics
High Average Low
0.42 0.16 0
(Dec 31 2011)   (Dec 31 2021)




Financial Statements
Bio Rad Laboratories Inc 's Equity $ 8,741 Millions Visit BIO's Balance sheet
Bio Rad Laboratories Inc 's Total Debt $ 1,200 Millions Visit BIO's Balance sheet
Source of BIO's Sales Visit BIO's Sales by Geography


Cumulative Bio Rad Laboratories Inc 's Total Debt to Equity

BIO's Total Debt to Equity for the trailling 12 Months

BIO Total Debt to Equity

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -9.09 % -0.44 % -5.33 % -4.12 % -29.65 %
Y / Y Total Debt TTM Growth 0.11 % 0.12 % 0.12 % 0.11 % 10789.58 %
Total Debt to Equity TTM 0.14 0.13 0.13 0.13 0.13
Total Ranking TTM # 158 # 631 # 36 # 19 # 8
Seq. Equity TTM Growth 3.86 % -0.36 % -13.49 % 1.54 % 13.74 %
Seq. Total Debt TTM Growth 0.03 % 0.03 % 0.03 % 0.03 % 0.04 %


On the trailing twelve months basis Due to the net new borrowings of 0.03% during the trailing twelve months finishing in the IV Quarter 2023, cumulativeTotal Debt to Equity improved to 0.14, above the Bio Rad Laboratories Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Laboratory Analytical Instruments industry BIO recorded the lowest Total Debt to Equity. While Total Debt to Equity total ranking has improved so far to 158, from total ranking in previous 12 month period at 631.

Explain Debt to Equity Ratio?
What is the structure of BIO´s Total Debt?
How valuable is the BIO´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 1
Healthcare Sector # 30
Within the Market # 158


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.15 0.05 0
(Dec 31 2017)   (Sep. 30, 2015)




Companies with similar Total Debt to Equity in the quarter ending Dec 31 2023, within Laboratory Analytical Instruments Industry Total Debt to EquityDec 31 2023 MRQ Total DebtDec 31 2023 MRQ Equity
Illumina Inc   0.26 $ 1,489.000  Millions$ 5,745.000  Millions
Bio rad Laboratories Inc   0.14 $ 1,199.538  Millions$ 8,741.133  Millions

Date modified: 2024-02-17T14:02:13+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com